SWE联合ATA(2015)指南超声模式在Bethesda Ⅲ类甲状腺结节中的应用价值

刘俊峰, 陈云璇, 郑英娟, 等. SWE联合ATA(2015)指南超声模式在Bethesda Ⅲ类甲状腺结节中的应用价值[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(18): 1400-1405. doi: 10.13201/j.issn.1001-1781.2018.18.009
引用本文: 刘俊峰, 陈云璇, 郑英娟, 等. SWE联合ATA(2015)指南超声模式在Bethesda Ⅲ类甲状腺结节中的应用价值[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(18): 1400-1405. doi: 10.13201/j.issn.1001-1781.2018.18.009
LIU Junfeng, CHEN Yunxuan, ZHENG Yingjuan, et al. The role of SWE and ATA(2015) guidelines combined mode in differentiation malignant from benign of Bethesda Ⅲ thyroid nodules[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(18): 1400-1405. doi: 10.13201/j.issn.1001-1781.2018.18.009
Citation: LIU Junfeng, CHEN Yunxuan, ZHENG Yingjuan, et al. The role of SWE and ATA(2015) guidelines combined mode in differentiation malignant from benign of Bethesda Ⅲ thyroid nodules[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(18): 1400-1405. doi: 10.13201/j.issn.1001-1781.2018.18.009

SWE联合ATA(2015)指南超声模式在Bethesda Ⅲ类甲状腺结节中的应用价值

详细信息
    通讯作者: 温德惠,E-mail:lucky0726cindy@163.com
  • 中图分类号: R581.3

The role of SWE and ATA(2015) guidelines combined mode in differentiation malignant from benign of Bethesda Ⅲ thyroid nodules

More Information
  • 目的:探讨第3代剪切波弹性成像技术(SWE)、ATA(2015)及SWE+ATA(2015)3种模式对性质不明确的甲状腺结节的诊断效能,明确超声在Bethesda Ⅲ类甲状腺良恶性结节鉴别中的诊断价值。方法:选取甲状腺细针穿刺细胞学检查(FNAB)诊断为意义不明确的细胞非典型性病变(AUS)/滤泡性病变(FLUS)的216例甲状腺结节作为研究对象,分析比较AUS/FLUS类结节的临床资料及二维超声特征,根据ATA(2015)超声指南分级标准对所有结节的二维超声图像进行分级,在新型声触诊组织成像定量剪切波弹性成像技术(VTIQ)模式下测量病灶内部横向剪切波速度(SWV),获取SWV的最大值(SWVmax)和平均值(SWVmean)。使用受试者工作特征曲线计算单一模式和联合模式鉴别甲状腺结节良恶性的最佳诊断界点,并根据诊断界点得出诊断效能等指标。结果:①在AUS/FLUS良恶性结节之间,患者的年龄、性别及结节的大小差异无统计学意义(P>0.05),152例AUS类结节多表现为不规则边界和微钙化且差异有统计学意义(P=0.005,P=0.004);②ATA(2015)指南超声模式对AUS类结节的良恶性评估有统计学意义(P=0.001),对FLUS类结节的良恶性鉴别未见明显统计学意义;③AUS/FLUS类结节的SWVmax和SWVmean值对结节良恶性的鉴别有统计学意义;④使用ATA(2015)+SWE联合模式诊断AUS类甲状腺结节的良恶性,得到曲线下面积为0.912大于单一诊断模式[ATA(2015):0.854,SWE:0.862],说明联合模式的诊断效能高于单一诊断模式。结论:SWE不仅能够弥补ATA(2015)在FLUS类甲状腺结节良恶性诊断中的不足,而且能有效提高ATA(2015)在AUS类甲状腺结节良恶性鉴别中的诊断效能。
  • 加载中
  • [1]

    ALEXANDER E K, KENNEDY G C, BALOCH Z W, et al.Preoperative diagnosis of benign thyroid nodules with indeterminate cytology[J].N Engl J Med, 2012, 367:705-715.

    [2]

    CIBAS E S, ALI S Z, NCI THYROID FNA STATE OF THE SCIENCE CONFERENCE.The Bethesda System For Reporting Thyroid Cytopathology[J].Am J Clin Pathol, 2009, 132:658-665.

    [3]

    HAUGEN B R, ALEXANDER E K, BIBLE K C, et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].Thyroid, 2016, 26:1-133.

    [4]

    AZIZI G, KELLER J M, MAYO M L, et al.Thyroid Nodules and Shear Wave Elastography:A New Tool in Thyroid Cancer Detection[J].Ultrasound Med Biol, 2015, 41:2855-2865.

    [5]

    IBITOYE R, WILKINS A.Thyroid papillary carcinoma after alemtuzumab therapy for MS[J].J Neurol, 2014, 261:1828-1829.

    [6]

    LEBOULLEUX S, TUTTLE R M, PACINI F, et al.Papillary thyroid microcarcinoma:time to shift from surgery to active surveillance[J]?Lancet Diabetes Endocrinol, 2016, 4:933-942.

    [7]

    YOO W S, CHOI H S, CHO S W, et al.The role of ultrasound findings in the management of thyroid nodules with atypia or follicularlesions of undetermined significance[J].Clin Endocrinol (Oxf), 2014, 80:735-742.

    [8]

    LEE S, SHIN J H, OH Y L, et al.Subcategorization of Bethesda system categoryⅢby ultrasonography[J].Thyroid, 2016, 26:836-842.

    [9]

    GWEON H M, SON E J, YOUK J H, et al.Thyroid nodules with Bethesda system III cytology:can ultrasonography guide the next step[J]?Ann Surg Oncol, 2013, 20:3083-3088.

    [10]

    LEE J H, HAN K, KIM E K, et al.Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines[J].Ann Otol Rhinol Laryngol, 2017, 126:625-633.

    [11]

    YOON J H, KWON H J, KIM E K, et al.Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS):a study applying Thyroid Imaging Reporting and Data System (TIRADS)[J].Clin Endocrinol (Oxf), 2016, 85:275-282.

    [12]

    AZIZI G, KELLER J M, MAYO M L, et al.Shear wave elastography and AfirmaTM gene expression classifier in thyroid nodules with indeterminate cytology:a comparison study[J].Endocrine, 2018, 59:573-584.

    [13]

    SAMIR A E, DHYANI M, ANVARI A, et al, Shearwave elastography for the preoperative risk stratification of follicular-patterned lesions of the thyroid:diagnostic accuracy and optimal measurement plane[J].Radiology, 2015, 277:565-573.

    [14]

    YOON J H, LEE H S, KIM E K, et al.Malignancy Risk Stratification of Thyroid Nodules:Comparison between the Thyroid Imaging Reporting and Data System and the 2014 American Thyroid Association Management Guidelines[J].Radiology, 2016, 278:917-924.

  • 加载中
计量
  • 文章访问数:  76
  • PDF下载数:  74
  • 施引文献:  0
出版历程
收稿日期:  2018-05-24

目录